文献速递肾小球疾病遗传性与小管间质肾病慢性肾脏病

炎症性肠病相关肾脏疾病:慢性组织学损伤、治疗及结局的影响

Kidney Diseases Associated With Inflammatory Bowel Disease: Impact of Chronic Histologic Damage, Treatments, and Outcomes.
PubMed 文献 · Kidney Int Rep · 2023-11-20

该回顾性队列研究纳入1994至2022年在Mayo Clinic接受原生肾活检的炎症性肠病(IBD)患者,分析111例随访患者。中位随访59个月,26%进展至肾衰竭;年龄、基线eGFR和组织学慢性化评分是肾衰竭的主要预测因素。实现缓解或肾功能稳定/改善的患者总体生存(肾衰竭+死亡)显著更优。

要点

  • IBD相关肾脏病最常见诊断为IgA肾病、慢性间质性肾炎和急性间质性肾炎。
  • 年龄、基线eGFR和组织学慢性化评分是肾衰竭的独立预测因素。
  • 实现缓解或肾功能稳定/改善与更好的总体生存相关。

核心结论

  • 约四分之一的IBD相关肾脏病患者可能进展至肾衰竭,主要决定因素为年龄、基线eGFR和肾活检慢性化程度。

研究设计与样本

  • 回顾性观察性队列研究,纳入1994至2022年在Mayo Clinic接受原生肾活检的IBD患者,最终分析111例随访患者。

主要发现

  • 最常见诊断为IgA肾病(22%)、慢性间质性肾炎(19%)和急性间质性肾炎(13%)。
  • 中位随访59个月期间,29例(26%)达到肾衰竭。
  • 多变量分析显示肾衰竭主要预测因素为年龄(HR 1.04,P=0.002)、基线eGFR(HR 0.94,P=0.003)和组织学慢性化评分(HR 4.01,P<0.001)。
  • 实现完全或部分缓解、或肾功能稳定或改善的患者总体生存(肾衰竭+死亡)显著更优。

临床怎么用

  • 对IBD相关肾脏病患者应评估年龄、基线eGFR和肾活检慢性化评分以预测肾衰竭风险。
  • 治疗应根据潜在病因进行个体化选择,并争取实现缓解或肾功能稳定/改善以改善总体生存。

局限性

  • 回顾性观察性设计,仅纳入单中心随访患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Kidney disease is a well-known extraintestinal manifestation (EIM) associated with inflammatory bowel disease (IBD), with a variety of underlying etiologies. However, little is known about the overall outcomes and predictors. METHODS: This is a retrospective, observational cohort study. Patients with IBD in whom a native kidney biopsy was performed at Mayo Clinic (Rochester, MN) between 1994 and 2022, were included. Demographic, clinical, and histologic characteristics of prognostic interest were collected. The main outcomes were kidney failure, disease remission, kidney function changes at last follow-up, and death. RESULTS: From a total cohort of 318 patients, we selected a study group of 111 patients followed-up with at our institution (45 ulcerative colitis [UC] and 66 Crohn's disease [CD]), with a mean age of 48 ± 17 years (40% females). IgA nephropathy (IgAN), chronic interstitial nephritis (CIN), and acute interstitial nephritis (AIN) were the most common diagnoses (22%, 19%, 13%, respectively). Median estimated glomerular filtration rate (eGFR) at presentation was 30 ml/min per 1.73 m2 (interquartile range [IQR]: 17-54) and urinary protein-to-creatinine ratio [UPCR] 0.8 g/g (0.3-3.4), without differences between IBD types. During a median follow-up of 59 months (12-109), 29 patients (26%) reached kidney failure. By multivariable analysis, the main predictors of kidney failure were age (hazard ratio [HR]: 1.04; P = 0.002), baseline eGFR (HR: 0.94; P = 0.003) and histologic chronicity score (HR: 4.01; P < 0.001). Therapeutic management varied according to underlying etiology. Global survival (kidney failure + death) was significantly better in patients who achieved complete or partial remission, or stabilization or improvement of kidney function. CONCLUSION: One-fourth of patients with IBD with kidney disease may reach kidney failure, and the main determinants of this outcome is age, baseline eGFR, and degree of chronicity in kidney biopsy.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Yandian F, Caravaca-Fontán F, Herrera Hernandez LP, et al. Kidney Diseases Associated With Inflammatory Bowel Disease: Impact of Chronic Histologic Damage, Treatments, and Outcomes. Kidney Int Rep. 2023. PMID: 38344742. doi:10.1016/j.ekir.2023.11.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。